GOLDMAN SACHS GROUP INC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2016$7,000
-46.2%
44,131
+5.3%
0.00%
Q2 2016$13,000
+30.0%
41,911
-22.6%
0.00%
Q1 2016$10,000
-77.8%
54,166
+110.0%
0.00%
Q4 2015$45,000
+104.5%
25,794
+118.2%
0.00%
Q3 2015$22,000
-62.7%
11,821
-53.0%
0.00%
Q2 2015$59,000
-56.6%
25,149
-19.2%
0.00%
Q1 2015$136,000
-31.0%
31,110
-24.1%
0.00%
Q4 2014$197,000
-0.5%
40,965
-14.1%
0.00%
Q3 2014$198,000
-11.2%
47,663
+25.9%
0.00%
Q2 2014$223,000
-32.8%
37,853
-27.3%
0.00%
Q1 2014$332,000
-36.4%
52,066
-5.1%
0.00%
Q4 2013$522,00054,8650.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q1 2015
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$22,387,0006.39%
First Washington CORP 185,250$893,0000.53%
PURA VIDA INVESTMENTS, LLC 80,500$388,0000.14%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,382,0000.06%
EMERALD ADVISERS, LLC 163,540$788,0000.04%
Catalyst Capital Advisors LLC 70,000$337,0000.04%
Burt Wealth Advisors 2,625$13,0000.01%
Spark Investment Management LLC 15,500$74,0000.01%
MYCIO WEALTH PARTNERS, LLC 12,000$58,0000.01%
Nicholas Investment Partners, LP 19,188$92,0000.01%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders